Which vector vaccines are already approved or under development in Switzerland?

Currently, the vector vaccine from Johnson & Johnson (Ad26.COV2.S) is approved for use in Switzerland. Recently, 150,000 doses of this vaccine were ordered and should be available from 5 October.

AstraZeneca's vaccine (ChAdOx1) has been submitted to Swissmedic for approval. This application for approval has since been withdrawn.